Incompatibility between lasalocid and chloramphenicol in broiler chicks after a long-term simultaneous administration.
Two growth experiments were conducted to evaluate in broiler chicks the compatibility between lasalocid medication in the feed (at 90 or 125 ppm) and a long-term administration of chloramphenicol either via the feed (500 ppm) or via the drinking water (500 mg/liter). The simultaneous administration of lasalocid and chloramphenicol generally caused severe growth depression, decreased feed intake and impaired feed conversion. Several chicks showed evident symptoms of intoxication, such as ataxia, leg weakness and paralysis. The development and frequency of these symptoms were dependent on the dosage of lasalocid and on the duration of the simultaneous administration. Biochemical examinations (Experiment 2) revealed in the affected chicks significant changes in several parameters, in particular a markedly increased activity of creatine kinase and GOT in the plasma. It confirmed that the observed leg weakness and paralysis were caused by myodegeneration.
D000821:Animal Feed; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001259:Ataxia / Q000139:chemically induced / Q000662:veterinary; D001835:Body Weight / Q000187:drug effects; D002645:Chickens / Q000254:growth & development / Q000502:physiology*; D002701:Chloramphenicol / Q000009:adverse effects*; D003402:Creatine Kinase / Q000097:blood; D004344:Drug Incompatibility; D004359:Drug Therapy, Combination; D004435:Eating / Q000187:drug effects; D005260:Female; D007832:Lasalocid / Q000009:adverse effects*; D008297:Male; D010243:Paralysis / Q000139:chemically induced / Q000662:veterinary; D011201:Poultry Diseases / Q000139:chemically induced
D002701:Chloramphenicol; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase; D007832:Lasalocid